Navigation Links
Bach to the blues, our emotions match music to colors
Date:5/16/2013

Whether we're listening to Bach or the blues, our brains are wired to make music-color connections depending on how the melodies make us feel, according to new research from the University of California, Berkeley. For instance, Mozart's jaunty Flute Concerto No. 1 in G major is most often associated with bright yellow and orange, whereas his dour Requiem in D minor is more likely to be linked to dark, bluish gray.

Moreover, people in both the United States and Mexico linked the same pieces of classical orchestral music with the same colors. This suggests that humans share a common emotional palette when it comes to music and color that appears to be intuitive and can cross cultural barriers, UC Berkeley researchers said.

"The results were remarkably strong and consistent across individuals and cultures and clearly pointed to the powerful role that emotions play in how the human brain maps from hearing music to seeing colors," said UC Berkeley vision scientist Stephen Palmer, lead author of a paper published this week in the journal Proceedings of the National Academy of Sciences.

Using a 37-color palette, the UC Berkeley study found that people tend to pair faster-paced music in a major key with lighter, more vivid, yellow colors, whereas slower-paced music in a minor key is more likely to be teamed up with darker, grayer, bluer colors.

"Surprisingly, we can predict with 95 percent accuracy how happy or sad the colors people pick will be based on how happy or sad the music is that they are listening to," said Palmer, who will present these and related findings at the International Association of Colour conference at the University of Newcastle in the U.K. on July 8. At the conference, a color light show will accompany a performance by the Northern Sinfonia orchestra to demonstrate "the patterns aroused by music and color converging on the neural circuits that register emotion," he said.

The findings may h
'/>"/>

Contact: Yasmin Anwar
yanwar@berkeley.edu
510-643-7944
University of California - Berkeley
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Diabetes Can Take a Toll on Your Emotions
2. Losing money, emotions and evolution
3. Latest Book by Rothstein Associates Cautions: Ignoring Emotions in the Workplace is High-Risk Behavior That Impacts the Bottom-Line
4. Social connections drive the upward spiral of positive emotions and health
5. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
6. Hospitals communication during residency matching may put stress on OB-GYN doctors-in-training
7. Lung nodule matching software dramatically increases radiologists efficiency
8. NIH tools facilitate matching cancer drugs with gene targets
9. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
10. Half-Match Marrow Transplants Help Some With Sickle Cell
11. Molecular portraits of tumours match patients with trials in everyday clinical practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... ... According to the The Media Post on July 9th teenagers ... medicinal use are more likely to abuse the substance. A recent study conducted by ... beneficial are more apt to use the substance, as opposed to their peers who ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start ... to produce first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the Commission ... November 30, 2019, during its recent meeting. , The Commission received renewal of ... compliance with the NCCA’s Standards for the Accreditation of Certification Programs. NCCA ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... changed its name in July to Kalamazoo Strength & Conditioning. , The name ... and “reflects the evolution of our training center over the past three years,” ...
(Date:7/29/2015)... ... , ... Today marks a significant achievement in bringing new monies into early ... led by a group of experienced investors, has tapped into an investor community passionate ... be a part of the fund. The Sofia Fund II is now closed ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2
... published the first comprehensive review of evidence on pneumococcal ... available in the on-line edition of the journal Lancet ... risk of pneumococcal infection by up to 40 fold, ... the PCV, and that the vaccine can protect HIV-infected ...
... San Diego have developed a novel computer technique to ... study, reported November 30 in PLoS Computational Biology relates ... Receptor Modulators (SERMs), which includes tamoxifen, the most prescribed ... side effects account for one-third of all drug development ...
... President of International Operations, MONROVIA, Calif., Nov. ... a leading developer, manufacturer and marketer of,minimally invasive ... has been named President and Chief Executive Officer. ... the annual shareholder,s,meeting in May 2007, replaces David ...
... Nov. 28 Novant Health(R) today announced ... leader,in developing and manufacturing medical devices for ... implement the Cardiocom System in its,Presbyterian Heart ... Hospital is one of the largest healthcare ...
... ASHBURN, Va., Nov. 28 Innocoll, Inc. announced ... that pursuant to,Rule 51(4) EPC, the European Patent ... applications which are both based on its proprietary,CollaRx ... Treatment of,Wounds" and Patent No. 1265648 entitled "Novel ...
... Corporation,("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, ... UK Medicines and,Healthcare products Regulatory Agency (MHRA) for ... sublingual spray (AD 923), an opioid,analgesic for the ... trial authorisation (CTA) covers two multi-centre pivotal,Phase III ...
Cached Medicine News:Health News:Pneumococcal conjugate vaccines can improve the lives of HIV-infected children 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 3Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 4Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 5Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 6Health News:Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 3Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 4Health News:Sosei Announces Approval to Start AD 923 Phase III Studies in Europe 2
(Date:7/29/2015)... SAN DIEGO , July 29, 2015 /PRNewswire/ ... Thursday, July 23, called the Alvarado Spine & ... orthopedic surgery and rehabilitation, focusing on spinal surgery ... method of patient care takes a patient experience-focused ... whatever clothing they feel comfortable in, rather than ...
(Date:7/29/2015)... FOREST, Calif. , July 29, 2015 ... ("Cryoport" or the "Company"), the leading provider ... life sciences industry, serving markets including immunotherapies, ... vaccine manufacturers, animal health, and reproductive medicine, ... the sale of common stock and warrants (the ...
(Date:7/29/2015)... 29, 2015  Ortho-Clinical Diagnostics, Inc. (OCD) today announced ... The assays address a range of important tests for ... troponin I. The scientific posters will be delivered during ... to be held July 26 - 30 in ... Clinical Diagnostics is emerging stronger than ever since becoming ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... Texas--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) ... of Proellex(TM), an oral drug being developed to,relieve ... with Proellex results in a statistically highly,significant improvement ... well tolerated., Study Details and Results , This ...
... Arrowhead Research,Corporation (NASDAQ: ARWR) announced the publication ... a study,demonstrating the anti-proliferative effect of the ... its lead anti-cancer,compound, CALAA-01., The paper, entitled ... Reduce Cell Proliferation In vitro and In,vivo", ...
Cached Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
... Health Record (EHR/EMR) and ... Specialties that we currently ... Cardiology, Dermatology, Family Medicine, ... Neurosurgery, Obstetrics and Gynecology, ...
... Software developed a touchscreen EHR and is ... a user can choose to use a ... maintain eye contact while recording encounter results. ... EHR also runs on a pen tablet ...
Dairylands Health Information Management solutions provides healthcare organizations a suite of integrated applications for managing patient records, optimizing reimbursement and regulatory complianc...
... WEBeDoctor® Physician-office® is ... for physicians, (Solo practice, ... care), to complete their ... practice. It is a ...
Medicine Products: